MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 22, 17:00
2056.55
37.15 (1.84%)
VOLUME 31,606
LIVE
NSE
May 22, 17:00
2055.75
34.9 (1.73%)
VOLUME 295,263

Stock Advice on Dr Reddys Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Dr Reddys Labs can cross Rs 2100: Ashish Chaturmohta 

5.55 pm | 22 May 2013 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Equity Brokers is of the view that Dr Reddys Laboratories can cross Rs 2100 and can see a move towards Rs 2150 in this s...

Dr Reddy's Lab top pick in pharma: IIFL Capital 

2.23 pm | 22 May 2013 |  Source: CNBC-TV18

Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...

Dr Reddys Labs to see deep correction: Sukhani 

12.17 pm | 22 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com feels Dr Reddys Laboratories is heading for deep correction. "It has broken down from a clear trading range on th...

Lupin, Sun Pharma, Dr Reddys Labs safe bets: Tater 

4.53 pm | 17 May 2013 |  Source: CNBC-TV18

Aashish Tater, Head of Research, Fortunewizard.com is of the view that Lupin, Sun Pharmaceutical Industries and Dr Reddys Laboratories are safe bets. ...

SPARC can give good returns: Aashish Tater 

4.45 pm | 17 May 2013 |  Source: CNBC-TV18

Aashish Tater, Head of Research, Fortunewizard.com feels that there is lot of money that can be made in Sun Pharma Advance Research Company....

Uptrend intact; pvt banks, pharma good: Phillip Capital 

10.38 am | 15 May 2013 |  Source: CNBC-TV18

For the index to touch 6100, Reliance Industries, Infosys and TCS will have to perform, says Vineet Bhatnagar opf Phillip Capital. He is bullish on p...

Hold Dr Reddys Laboratories: Prakash Diwan 

6.10 pm | 14 May 2013 |  Source: CNBC-TV18

One can hold Dr Reddys Laboratories, says Prakash Diwan, Chief Portfolio Strategist of Prakash Diwan's Wealth Circle, ECR. ...

Maruti a yen play; like NTPC, midcap pharma: Kotak's Prasad 

10.19 am | 13 May 2013 |  Source: CNBC-TV18

Maruti is a play on the yen more than anything, says Sanjeev Prasad of Kotak Institutional Equities. He is bearish on FMCG stocks, and says will not b...

Buy Dr Reddys Labs 2000 Call: VK Sharma 

4.38 pm | 09 May 2013 |  Source: CNBC-TV18

VK Sharma of HDFC Securities said one could consider buying Dr Reddys Labs 2000 Call, with a stop loss of Rs 40....

Nomura 'overweight' on rate-cyclicals, defensives 

3.36 pm | 02 May 2013 |  Source: Reuters

Nomura Equity Research is "overweight" on rate cyclicals and defensive growth plays but remains "underweight" on domestic growth cyclicals....

Buy Dr Reddys Laboratories, says Sukhani 

1.51 pm | 30 Apr 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that, one should buy Dr Reddys Laboratories....

Dr Reddys Labs may see 5-7% upside: Malkan 

6.11 pm | 29 Apr 2013 |  Source: CNBC-TV18

Dr Reddys Labs may see 5-7% upside, says Vishal B Malkan, malkansview.com....

Super Six stocks you can bet on April 22 

9.11 am | 22 Apr 2013 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Rajesh Jain, Religare Securities, Vikrant Jadeja, vibranttrades.com and Vishal Malkan, malkansview.com, pl...

Buying opportunities seen in HPCL, Dr Reddys Labs: Sukhani 

2.16 pm | 13 Apr 2013 |  Source: CNBC-TV18

Buying opportunities is seen in HPCL and Dr Reddys Labs at current levels, says Sudarshan Sukhani, s2analytics.com....

Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.